Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

This article reports the affibody-based nanoprobes specifically target and image human epidermal growth factor receptor type 2 (HER2)-expressing cells and tumors. The affibody molecules are a promising class of targeting ligands with simple, robust, and precise structure and high affinity. Using nea...

Full description

Saved in:
Bibliographic Details
Published inBiomaterials Vol. 32; no. 8; pp. 2141 - 2148
Main Authors Gao, Jinhao, Chen, Kai, Miao, Zheng, Ren, Gang, Chen, Xiaoyuan, Gambhir, Sanjiv S., Cheng, Zhen
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.03.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This article reports the affibody-based nanoprobes specifically target and image human epidermal growth factor receptor type 2 (HER2)-expressing cells and tumors. The affibody molecules are a promising class of targeting ligands with simple, robust, and precise structure and high affinity. Using near-infrared (NIR) quantum dots (QDs) and iron oxide (IO) nanoparticles as two representative nanomaterials, we designed anti–HER2 affibody molecules with a N-terminus cysteine residue (Cysteine-ZHER2:342) and precisely conjugated with maleimide-functionalized nanoparticles to make nanoparticle-affibody conjugates. The in vitro and in vivo study showed the conjugates are highly specific to target and image HER2-expressing cells and tumors. This work indicated the nanoparticle-affibody conjugates may be excellent candidates as targeting probes for molecular imaging and diagnosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
ISSN:0142-9612
1878-5905
1878-5905
DOI:10.1016/j.biomaterials.2010.11.053